AT2 antagonist-sensitive potentiation of angiotensin II-induced constriction by NO blockade and its dependence on endothelium and P450 eicosanoids in rat renal vasculature

British Journal of Pharmacology

Volumn 124, Issue 5, 1998, Pages 946-952

  Muller, Catherine ^a   Endlich, Karlhans ^a   Helwig, Jean Jacques ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSERM   (France)

Author keywords

Arachidonic acid metabolism; Cytochrome P450; Isolated perfused kidney; No synthase; Receptors; Vascular resistance

Indexed keywords

3 [(3 CHOLAMIDOPROPYL)DIMETHYLAMMONIO] 1 PROPANESULFONIC ACID; 5,8,11,14 ICOSATETRAYNOIC ACID; ALPHA NAPHTHOFLAVONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CYTOCHROME P450; ICOSANOID; INDOMETACIN; NITRIC OXIDE; NORADRENALIN; ALPHA-NAPHTHOFLAVONE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ARACHIDONIC ACID; BENZOFLAVONE DERIVATIVE; BOSENTAN; ENDOTHELIN RECEPTOR; ENZYME INHIBITOR; SULFONAMIDE;

ANIMAL TISSUE; ARTICLE; KIDNEY BLOOD VESSEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; KIDNEY; METABOLISM; PERFUSION; PHYSIOLOGY; VASCULAR RESISTANCE; VASCULARIZATION; WISTAR RAT;

5,8,11,14-EICOSATETRAYNOIC ACID; ANGIOTENSIN II; ANIMALS; ARACHIDONIC ACID; BENZOFLAVONES; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; KIDNEY; MALE; NITRIC OXIDE; NOREPINEPHRINE; PERFUSION; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RECEPTORS, ENDOTHELIN; SULFONAMIDES; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0031595717     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701906     Document Type: Article

References (39)

1. ADACHI, Y., HASHIMOTO, K., HISA, H., YOSHIDA, M., SUZUKIKUSABA, M. & SATOH, S. (1996). Angiotensin II-induced renal responses in anesthetized rabbits: Effects of N(omega-)nitro-L-arginine methyl ester and losartan. Eur. J. Pharmacol., 308, 165-171.
2. ALONSO-GALICIA, M., DRUMMOND, H.A., REDDY, K.K., FALCK, J.R. & ROMAN, R.J. (1997). Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension, 29, 320-325.
3. BARTHELMEBS, M., KRIEGER, J.P., GRIMA, M., NISATO, D. & IMBS, J.L. (1996). Vascular effects of [Arg(8)]vasopressin in the isolated perfused rat kidney. Eur. J. Pharmacol., 314, 325-332.
4. BAUERSACHS, J., POPP, R., HECKER, M., SAUER, E., FLEMING, I. & BUSSE, R. (1996). Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation, 94, 3341-3347.
5. BAYLIS, C., SLANGEN, B., HUSSAIN, S. & WEAVER, C. (1996). Relationship between basal NO release and cyclooxygenase products in the normal rat kidney. Am. J. Physiol., 271, R1327-R-1334.
6. BHARDWAJ, R. & MOORE, P.K. (1989). The effect of arginine and nitric oxide on resistance blood vessels of the perfused rat kidney. Br. J. Pharmacol., 97, 739-744.
7. BOTTARI, S.P., DE GASPARO, M., STECKELINGS, U.M. & LEVENS, N.R. (1993). Angiotensin II receptor subtypes: Characterization, signalling mechanisms, and possible physiological implications. Front Neuroendocrinol., 14, 123-171.
8. BRECHLER, V., JONES, P.W., LEVENS, N.R., DE GASPARO, M. & BOTTARI, S.P. (1993). Agonistic and antagonistic properties of angiotensin analogs at the AT2 receptor in PC12W cells. Reg. Peptides, 44, 207-213.
9. BRYANT, C.E., ALLCOCK, G.H. & WARNER, T.D. (1995). Comparison of effects of chronic and acute administration of N-G-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses. Br. J. Pharmacol., 114, 1673-1679.
10. CHANG, T.K., GONZALEZ, F.J. & WAXMAN, D.J. (1994). Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyl-dithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Arch. Bioehem. Biophys., 311, 437-442.
11. CLOZEL, M., BREU, V., GRAY, G.A., KALINA, B., LÖFFLER, B.M., BURRI, K., CASSAL, J.M., HIRTH, G., MÜLLER, M., NEIDHART, W. & RAMUZ, H. (1994). Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther., 270, 228-235.
12. COCKS, T.M. & ANGUS, J.A. (1983). Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature, 305, 627-630.
13. DOUGLAS, J.G. & HOPFER, U. (1994). Novel aspect of angiotensin receptors and signal transduction in the kidney. Annu. Rev. Physiol., 56, 649-669.
14. EMORI, T., HIRATA, Y., OHTA, K., KANNO, K., EGUCHI, S., IMAI, T., SHICHIRI, M. & MARUMO, F. (1991). Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension, 18, 165-170.
15. GARDES, J., GONZALEZ, M.F., ALHENC-GELAS, F. & MENARD, J. (1994). Influence of sodium diet of L-NAME effects on renin release and renal vasoconstriction. Am. J. Physiol., 267, F798-F804.
16. HARDER, D.R., CAMPBELL, W.B. & ROMAN, R.J. (1995). Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J. Vasc. Res., 32, 79-92.
17. IMAI, T., HIRATA, Y., EMORI, T., YANAGISAWA, M., MASAKI, T. & MARUMO, F. (1992). Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension, 19, 753-757.
18. IMIG, J.D., NAVAR, E.G., ROMAN, R.J., REDDY, K.K. & FALCK, J.R. (1996a). Actions of epoxygenase metabolites on the preglomerular vasculature. J. Am. Soc. Nephrol., 7, 2364-2370.
19. IMIG, J.D., ZOU, A.P., STEC, D.E., HARDER, D.R., FALCK, J.R. & ROMAN, R.J. (1996b). Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am. J. Physiol., 270, R217-R227.
20. JUNCOS, L.A., ITO, S., CARRETERO, O.A. & GARVIN, E.L. (1994). Removal of endothelium-dependent relaxation by antibody and complement in afferent arterioles. Hypertension, 23, 154-159.
21. KAUFMANN, M.A., CASTELLI, I., PARGGER, H. & DROP, L.J. (1995). Nitric oxide dose-response study in the isolated perfused rat kidney after inhibition of endothelium-derived relaxing factor synthesis: The role of serum albumin. J. Pharmacol. Exp. Ther., 273, 855-862.
22. KHATSENKO, O. & KIKKAWA, Y. (1997). Nitric oxide differentially affects constitutive cytochrome P450 isoforms in rat liver. J. Pharmacol. Exp. Ther., 280, 1463-1470.
23. KING, A.J. & BRENNER, B.M. (1991). Endothelium-derived vasoactive factors and the renal vasculature. Am. J. Physiol., 260, R653-R662.
24. KOHNO, M., HORIO, T., IKEDA, M., YOKOKAWA, K., FUKUI, T., YASUNARI, K., KURIHARA, N., TAKEDA, T. & JOHCHI, M. (1992). Angiotensin-II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Int., 42, 860-866.
25. LO, M., LIU, K.L., LANTELME, P. & SASSARD, J. (1995). Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J. Clin. Invest., 95, 1394-1397.
26. MASSFELDER, T., STEWART, A.F., ENDLICH, K., SOIFER, N., JUDES, C. & HELWIG, J.J. (1996). Parathyroid hormone-related protein detection and interaction with NO and cyclic AMP in the renovascular system. Kidney Int., 50, 1591-1603.
27. MCGIFF, J.C. (1991). Cytochrome P-450 metabolism of arachidonic acid. Annu. Rev. Pharmacol. Toxicol., 31, 339-369.
28. MULLER, C., ENDLICH, K., BARTHELMEBS, M. & HELWIG, J.J. (1997). AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature. Br. J. Pharmacol., 122, 1495-1501.
29. NAVAR, L.G., INSCHO, E.W., MAJID, D.S.A., IMIG, J.D., HARRISON-BERNARD, L.M. & MITCHELL, K.D. (1996). Paracrine regulation of the renal microcirculation. Physiol. Rev., 76, 425-536.
30. OYEKAN, A.O. (1994). Role of the cytochrome P450 enzyme system as a humoral modulator of vasomotor responses in rat renal vasculature. J. Cardiovasc. Pharmacol., 24, 238-246.
31. OYEKAN, A.O. (1995). The suppression by lipopolysaccharide of cytochrome P450-dependent renal vasodilation in the rat is mediated by nitric oxide. Eur. J. Pharmacol., 277, 123-132.
32. PAREKH, N., DOBROWOLSKI, L., ZOU, A.P. & STEINHAUSEN, M. (1996). Nitric oxide modulates angiotensin II- and norepinephrine-dependent vasoconstriction in rat kidney. Am. J. Physiol., 270, R630-R635.
33. RADERMACHER, J., FORSTERMANN, U. & FROLICH, J.C. (1990). Endothelium-derived relaxing factor influences renal vascular resistance. Am. J. Physiol., 259, F9-F17.
34. SIRAGY, H.M. & CAREY, R.M. (1997). The subtype 2 (AT(2)) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J. Clin. Invest., 100, 264-269.
35. SIRAGY, H.M. & CAREY, R.M. (1996). The subtype-2 (AT(2)) angiotensin receptor regulates renal cyclic guanosine 3′,5′-monophosphate and AT(1) receptor-mediated prostaglandin E(2) production in conscious rats. J. Clin. Invest., 97, 1978-1982.
36. STEPHAN, D., BARTHELMEBS, M., KRIEGER, J.P., DECKER, N., ROCHAT, C. & IMBS, J.L. (1990). Effect of tertalol and of its metabolites and structural analogues in isolated perfused rat kidney vasculature. J. Cardiovasc. Pharmacol., 16, 338-346.
37. WINK, D.A., OSAWA, Y., DARBYSHIRE, J.F., JONES, C.R., ESHENAUER, S.C. & NIMS, R.W. (1993). Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys., 300, 115-123.
38. ZHUO, J.L., DEAN, R., MACGREGOR, D., ALCORN, D. & MENDELSOHN, F.A.O. (1996). Presence of angiotensin II AT(2) receptor binding sites in the adventitia of human kidney vasculature. Clin. Exp. Pharmacol. Physiol., 23, S147-S154.
39. ZIYYAT, A., ZHANG, B.L. & BENZONI, D. (1996). Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat. Br. J. Pharmacol., 119, 388-392.